Unified PMS Compliance Framework: One System for All Markets — The Practical Solution (2026)

The Unified PMS Compliance Framework: One System for All Markets

If you manufacture medical devices for multiple markets — US, EU, Canada, Japan, Australia, and beyond — you face a fundamental challenge: each jurisdiction has its own PMS regulations, its own reporting timelines, its own documentation requirements, and its own inspection approach. Building a separate PMS system for each market is expensive, error-prone, and ultimately unsustainable.

The practical solution is a unified PMS compliance framework — a single system designed to satisfy the most stringent requirements from any jurisdiction, with modular add-ons for jurisdiction-specific obligations. This guide explains why this approach works, how to build it, and how it transforms your RA/QA team's day-to-day operations.

Why a Unified System Works

Despite different regulations, the core PMS requirements across all jurisdictions share 85-90% commonality:

* China requires annual quality reports separately.

The first 7 rows are universal. Build your base system to cover these, then add the jurisdiction-specific elements (last 4 rows) as modules.

The Framework Architecture

Layer 1: ISO 13485:2016 Foundation

ISO 13485:2016 Section 8.2 (Monitoring and Measurement) provides the backbone:

• Section 8.2.1: Feedback — systematic processes to collect customer feedback including complaints
• Section 8.2.2: Complaint handling — documented procedures for receiving, evaluating, and investigating
• Section 8.2.3: Reporting to regulatory authorities — processes for determining reportability and submitting reports

Build all PMS procedures to meet ISO 13485 first, then map jurisdiction-specific requirements on top.

Layer 2: MDSAP Harmonization

MDSAP Chapter 5 (Measurement, Analysis, and Improvement) audits PMS across 5 jurisdictions simultaneously. Designing your system to pass MDSAP means you automatically satisfy FDA, Health Canada, Brazil, Japan, and Australia PMS requirements in a single audit.

Layer 3: EU MDR Enhancement

Layer the EU MDR-specific requirements on top: PMS Plan (Article 84), PSUR (Article 86), PMCF (Annex XIV Part B), and trend reporting (Article 88). These are the most documentation-intensive PMS requirements globally.

Layer 4: Jurisdiction-Specific Modules

Add modules for unique requirements:

• Japan: Re-examination study management, designated safety manager, GVP compliance
• China: Annual quality report, provincial monitoring center reporting, Chinese Agent coordination
• South Korea: PMS study protocol management, MFDS reporting
• UK: Yellow Card reporting, UK Responsible Person coordination

How to Build It: The 8-Component System

Component 1: Unified Complaint Intake

What: A single intake point for all customer feedback from all markets, with automatic routing based on device, geography, and severity.

How it helps RA/QA: Instead of checking multiple inboxes and systems, you have one queue. Every complaint gets the same initial evaluation against the most stringent criteria (EU MDR serious incident definition), which automatically satisfies all lesser thresholds.

Component 2: Multi-Jurisdiction Reportability Engine

What: A decision matrix that evaluates each event against every jurisdiction's reporting criteria simultaneously.

How it helps RA/QA: When you evaluate a complaint, the system tells you: "This event is reportable to FDA (30-day MDR), EU NCA (10-day serious incident), and Health Canada (10-day mandatory report). Not reportable to Japan per GVP criteria." One evaluation, all jurisdictions covered.

Component 3: Automated External Monitoring

What: Continuous monitoring of regulatory databases across all jurisdictions for events related to your devices and similar devices.

How it helps RA/QA: Instead of spending hours manually searching MAUDE, FDA recalls, HC recalls, and other databases, you receive pre-screened alerts with relevance scoring. TrueMedDevice provides exactly this capability — monitoring 548,000+ records from 7 FDA and Health Canada data sources, with automated matching to your device profiles.

The external monitoring challenge: This is the component where most small and medium manufacturers fail. Manual monitoring across multiple databases is time-consuming and inconsistent. Without automated tools, external PMS monitoring becomes the most common gap identified in audits. Regulatory intelligence platforms eliminate this gap by providing:

• Aggregated search across multiple national databases
• Product-profile matching that filters relevant signals from noise
• Pre-screened evidence cards with rationale for why a signal is relevant
• Audit-ready documentation showing what was monitored, when, and what action was taken

Component 4: Statistical Trend Engine

What: Automated statistical analysis of complaint data, adverse events, and quality metrics with predefined thresholds for action.

How it helps RA/QA: Instead of manually counting complaints and hoping you notice a trend, the system applies control charts and statistical tests to detect significant changes. When a threshold is crossed, it generates an alert. This satisfies EU MDR Article 88 trend reporting requirements and FDA QMSR expectations.

Component 5: Integrated CAPA Management

What: CAPA system that can be triggered by any PMS data source (internal complaint, external signal, trend alert, audit finding) with built-in effectiveness verification tracking.

How it helps RA/QA: PMS findings flow directly into CAPA evaluation without manual handoff. The system tracks whether PMS-triggered CAPAs were verified as effective and whether the underlying PMS trend resolved.

Component 6: Document Generation Engine

What: Automated generation of jurisdiction-specific PMS deliverables from a single data set.

How it helps RA/QA: Same PMS data produces an FDA annual report, an EU PSUR, an HC summary, and a Japan GVP report — without duplicate data entry. Templates aligned with MDCG 2022-21 (PSUR) and jurisdiction-specific formats.

Component 7: Risk Management Integration

What: Direct linkage between PMS findings and ISO 14971 risk management files.

How it helps RA/QA: When PMS data reveals a new failure mode or changes the probability of a known risk, the system flags the risk management file for update. This closes the loop that regulators audit most aggressively.

Component 8: Inspection-Ready Evidence Pack

What: On-demand generation of inspection-ready documentation packages showing PMS system operation, data analysis, and resulting actions.

How it helps RA/QA: When an inspector arrives (or an NB audit is scheduled), you generate a complete PMS evidence package in minutes instead of scrambling for days. This is the output that TrueMedDevice's evidence pack export provides for external monitoring — a formatted, timestamped record of every regulatory signal monitored, evaluated, and actioned.

How the Solution Changes RA/QA Day-to-Day Work

Before: The Fragmented Approach

Total: ~15 hours/month on PMS operations + significant audit preparation time

After: The Unified Approach

Total: ~8 hours/month on PMS operations + minimal audit preparation time

The unified approach cuts PMS operational time by approximately 50% while simultaneously improving quality, consistency, and audit readiness.

Implementation Roadmap

You don't need to build everything at once. Here is a phased approach:

Phase 1 (Months 1-3): Foundation

1. Audit current PMS system against the gap analysis checklist
2. Consolidate complaint handling into a single system
3. Implement automated external monitoring for FDA and Health Canada databases using TrueMedDevice
4. Document PMS procedures to ISO 13485 standard

Phase 2 (Months 4-6): Enhancement

1. Implement statistical trending for complaint data
2. Build multi-jurisdiction reportability decision matrix
3. Create EU MDR PMS Plan and PSUR templates
4. Connect PMS outputs to risk management file update process

Phase 3 (Months 7-12): Optimization

1. Implement PMCF program (if EU MDR applicable)
2. Add jurisdiction-specific modules (Japan GVP, China annual report)
3. Automate evidence pack generation for inspections
4. Conduct first unified management review with PMS data

The Business Case: Why PMS Excellence Pays

Investing in a unified PMS system is not just a compliance cost — it reduces operational risk and protects your business:

• Avoid recall costs: Average Class I recall costs $3M-$10M+ (logistics, customer notification, replacement, regulatory). Proactive PMS detects issues earlier, enabling corrections before recalls.
• Avoid consent decrees: FDA consent decrees cost $10M-$100M+ and can shut down operations for years. PMS compliance is a primary factor in whether FDA pursues enforcement.
• Reduce audit findings: Each major MDSAP finding risks your device licence. Each NB major nonconformity requires remediation and potential certificate suspension.
• Speed to market: Companies with mature PMS systems get faster NB reviews and smoother regulatory submissions because they can demonstrate post-market data quality.
• Competitive advantage: In procurement, hospitals increasingly evaluate manufacturers' post-market safety track records. A clean 483 history and proactive PMS program differentiates you.